The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity

Figure 4

Knocking down ICOSL did not change the proliferation, migration, and invasion ability of NPC cells in vitro. (a) mRNA and protein levels from four NPC cell lines; (b) qRT-PCR and western blot prove that ICOSL siRNA strongly reduces the ICOSL production in NPC cell in both mRNA and protein levels; (c) MTT assay shows that reduced ICOSL does not change the proliferation ability of NPC cells; (d) reduced ICOSL did influence the migration capability of NPC cells; (e) reduced ICOSL did influence the invasion capability of NPC cells.

(a)

(b)

(c)

(d)

(e)